New Jersey’s Prescription Monitoring Program integrates data from multiple state agencies, including the Department of Health, the Division of Consumer Affairs, the Office of the Attorney General, and other law enforcement bodies, to power the Overdose Data Dashboard. The Department of Health uses the dashboard to make decisions about access to medications, such as naloxone, designed to rapidly reverse opioid overdose and harm reduction services.
